Big Moving Stock chart patterns and volume.
The Hot Industries
Health Care Plans 5
Aerospace/Defense Products & Services 2
The Hot Sectors
Industrial Goods 3
CELG Celgene Corporation
Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and immune-inflammatory related diseases in the United States and internationally. The companys commercial stage products include REVLIMID, an oral immunomodulatory drug for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and mantle cell lymphoma; VIDAZA, a pyrimidine nucleoside analog to treat intermediate-2 and high-risk MDS, and chronic myelomonocytic leukemia, as well as acute myeloid leukemia (AML); ABRAXANE, a solvent-free chemotherapy product for the treatment of breast, non-small cell lung, pancreatic, and gastric cancers; and POMALYST/IMNOVID for the treatment of multiple myeloma. Its commercial stage products also comprise THALOMID for the patients with multiple myeloma and for the acute treatment of the cutaneous manifestations of erythema nodosum leprosum; ISTODAX to treat cutaneous T-cell lymphoma; and FOCALIN, FOCALIN XR, and RITALIN LA products. The companys pre clinical and clinical stage products consist of OTEZLA for the treatment of psoriatic arthritis, psoriasis, and ankylosing spondylitis; CC-122 and CC-220 to treat hematological and solid tumor cancers; cellular therapies, such as PDA-001 and PDA-002 for Crohns and peripheral arterial diseases; CC-486, to treat MDS, AML, and solid tumors; Sotatercept and ACE-536 for the treatment of anemia in patients with rare blood disorders; CC-223 and CC-115 for lymphomas, hepatocellular, and prostate cancers; and CC-292 for the treatment of chronic lymphocytic leukemia and lymphomas. It has strategic drug discovery collaboration with Abide Therapeutics to enhance the treatment paradigm for patients with immune disorders. Celgene Corporation was founded in 1980 and is headquartered in Summit, New Jersey.
4 Screaming Growth Stocks to Buy23 Jan 2015, 9:46 am4 Screaming Growth Stocks to Buy
Celgene to Use Zymeworks' Azymetric Platform for New Drugs - Analyst Blog22 Jan 2015, 1:10 pmCelgene (CELG) inked a deal with Zymeworks for the research, development and commercialization of bi-specific antibody therapeutics.
Critical Alerts For Apple, VoxelJet, Celgene, TASER International and Finisar Released By InvestorsObserver22 Jan 2015, 7:44 amCHICAGO, Jan. 22, 2015 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AAPL, VJET, CELG, TASR and FNSR. To see what our analysts have discovered about a particular stock, read the InvestorsObserver's PriceWatch Alert by selecting the corresponding link....
The Zacks Analyst Blog Highlights: AbbVie, Gilead and Celgene - Press Releases22 Jan 2015, 7:30 amThe Zacks Analyst Blog Highlights: AbbVie, Gilead and Celgene
Biotech Stock Roundup: EU Approvals for AbbVie & Celgene Drugs, CytRx Partial Clinical Hold Lifted - Analyst Blog21 Jan 2015, 9:02 amThe hepatitis C virus (HCV) pricing battle is heating up with Gilead (GILD) signing on with quite a few PBMs and health care benefit companies for Sovaldi and Harvoni.
Stock Market News for January 21, 2015 - Market News21 Jan 2015, 8:10 amBenchmarks ended Tuesday’s choppy trading session in the green led by gains from technology shares
Zacks Rank #1 Additions for Thursday - Tale of the Tape15 Jan 2015, 7:30 amHere are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Thursday
Jim Cramer's Top Stock Picks: AAPL FLEX DIS CELG HALO14 Jan 2015, 4:13 amSearch Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener. NEW YORK (TheStreet) -- Here are some of the hot stocks Jim Cramer talked about on Tuesday's Mad Money on CNBC: AAPL data by YCharts Apple : Cramer said based on revised estimates, Apple trades at just 11 times estimates. FLEX data by YCharts Flextronics : Consumer technology is heating up and ...
Jim Cramer's Top Stock Picks: ISIS CELG NPSP AA ACOR13 Jan 2015, 4:28 amSearch Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener. NEW YORK (TheStreet) -- Here are some of the hot stocks Jim Cramer talked about on Monday's Mad Money on CNBC: ISIS data by YCharts Isis Pharmaceuticals , Celgene and NPS Pharmaceuticals : Cramer said these are just some of the many biotech stocks that are helping to combat oil's drag on the ...
Earnings Watch: Updates, advisories and surprises12 Jan 2015, 7:11 amA roundup of the latest corporate earnings reports and what companies are saying about future quarters.